Detalles de la búsqueda
1.
Real-world effectiveness and safety of direct-acting antivirals in patients with cirrhosis and history of hepatic decompensation: Epi-Ter2 Study.
Liver Int
; 41(8): 1789-1801, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33655628
2.
Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real-world experience?
J Gastroenterol Hepatol
; 36(7): 1944-1952, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33171526
3.
Real-world experience with Grazoprevir/Elbasvir in the treatment of previously "difficult to treat" patients infected with hepatitis C virus genotype 1 and 4.
J Gastroenterol Hepatol
; 35(7): 1238-1246, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31734959
4.
The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study.
BMC Infect Dis
; 18(1): 580, 2018 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30445916
5.
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients.
Expert Rev Anti Infect Ther
; : 1-6, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722307
6.
Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure.
Clin Exp Hepatol
; 9(4): 320-334, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38774196
7.
Efficacy of 8- versus 12-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C patients eligible for 8-week regimen in a real-world setting.
Arch Med Sci
; 18(6): 1460-1466, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36457986
8.
HCV Genotype Has No Influence on the Incidence of Diabetes-EpiTer Multicentre Study.
J Clin Med
; 11(2)2022 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35054072
9.
Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study.
J Clin Med
; 11(17)2022 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36079122
10.
HCV resistance-associated substitutions following direct-acting antiviral therapy failure - Real-life data from Poland.
Infect Genet Evol
; 93: 104949, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34087494
11.
Hepatotropic Properties of SARS-CoV-2-Preliminary Results of Cross-Sectional Observational Study from the First Wave COVID-19 Pandemic.
J Clin Med
; 10(4)2021 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33572429
12.
Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics.
J Clin Med
; 10(15)2021 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34362064
13.
Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study.
World J Gastroenterol
; 27(18): 2177-2192, 2021 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34025072
14.
Nosocomial COVID-19 Infection and Severe COVID-19 Pneumonia in Patients Hospitalized for Alcoholic Liver Disease: A Case Report.
Am J Case Rep
; 21: e927452, 2020 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32973125
15.
Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA.
Expert Rev Anti Infect Ther
; 18(10): 1045-1054, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32538232
16.
Real World Experience of Chronic Hepatitis C Retreatment with Genotype Specific Regimens in Nonresponders to Previous Interferon-Free Therapy.
Can J Gastroenterol Hepatol
; 2019: 4029541, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30941326
17.
Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals?
J Interferon Cytokine Res
; 38(2): 93-100, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29443655
18.
Changes in patient profile, treatment effectiveness, and safety during 4 years of access to interferon-free therapy for hepatitis C virus infection.
Pol Arch Intern Med
; 130(2): 163-172, 2020 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32031541
19.
Rescue therapy with intravenous silibinin in liver transplant recipients with recurrent HCV hepatitis - two case reports.
Ann Transplant
; 19: 161-4, 2014 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-24714452
20.
Impact of antiviral treatment on survival in HCV-positive liver recipients.
Ann Transplant
; 19: 367-72, 2014 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25073736